Medtronic PLC $MDT Shares Acquired by Dnca Finance

Dnca Finance lifted its stake in Medtronic PLC (NYSE:MDT) by 17.2% during the second quarter, Holdings Channel reports. The institutional investor owned 95,550 shares of the medical technology company’s stock after acquiring an additional 14,000 shares during the quarter. Dnca Finance’s holdings in Medtronic were worth $8,329,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. 1248 Management LLC purchased a new stake in Medtronic in the 1st quarter worth approximately $26,000. Twin Tree Management LP acquired a new position in shares of Medtronic in the 1st quarter valued at $29,000. Activest Wealth Management boosted its holdings in Medtronic by 3,577.8% during the first quarter. Activest Wealth Management now owns 331 shares of the medical technology company’s stock worth $30,000 after buying an additional 322 shares in the last quarter. GFG Capital LLC acquired a new stake in Medtronic during the second quarter valued at $36,000. Finally, True Wealth Design LLC increased its holdings in Medtronic by 49.8% in the second quarter. True Wealth Design LLC now owns 421 shares of the medical technology company’s stock valued at $37,000 after buying an additional 140 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MDT has been the topic of several recent analyst reports. Argus increased their target price on shares of Medtronic from $105.00 to $115.00 and gave the stock a “buy” rating in a research note on Tuesday, August 26th. Needham & Company LLC reaffirmed a “hold” rating on shares of Medtronic in a report on Thursday, August 14th. Jefferies Financial Group reissued a “hold” rating and issued a $110.00 price objective on shares of Medtronic in a report on Wednesday, November 19th. Robert W. Baird boosted their price objective on Medtronic from $103.00 to $109.00 and gave the company a “neutral” rating in a research report on Wednesday, November 19th. Finally, Cowen reaffirmed a “buy” rating on shares of Medtronic in a research note on Friday, November 14th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $110.44.

Medtronic Price Performance

NYSE:MDT opened at $101.39 on Friday. The stock has a 50 day moving average of $96.79 and a two-hundred day moving average of $92.22. Medtronic PLC has a 12 month low of $79.29 and a 12 month high of $106.33. The firm has a market cap of $129.99 billion, a P/E ratio of 27.33, a price-to-earnings-growth ratio of 2.67 and a beta of 0.71. The company has a current ratio of 2.42, a quick ratio of 1.80 and a debt-to-equity ratio of 0.57.

Medtronic (NYSE:MDT) last released its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.05. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.The business had revenue of $8.96 billion for the quarter, compared to the consensus estimate of $8.86 billion. During the same quarter last year, the business posted $1.26 earnings per share. The business’s quarterly revenue was up 6.6% compared to the same quarter last year. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, analysts expect that Medtronic PLC will post 5.46 earnings per share for the current fiscal year.

Medtronic Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Shareholders of record on Friday, December 26th will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic’s payout ratio is 76.55%.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.